Friendly” labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve ...

Few celebrity chefs are as instantly recognisable as Gordon Ramsay, whose razor-sharp tongue and unforgiving food standards ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Oprah Winfrey, 71, revealed the reason she returned to taking GLP-1 drugs after taking a year-long break while voicing strong ...

As the use of GLP-1 weight-loss drugs grows, new research from Circana LLC reveals that users are not abandoning restaurants ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

A Kaiser Family Foundation study revealed about one in eight adults in the US say they’re taking a GLP-1 drug such as Ozempic ...

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.